Header Logo

Connection

Glenda Gray to HIV-1

This is a "connection" page, showing publications Glenda Gray has written about HIV-1.
Connection Strength

2,657
  1. Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults. N Engl J Med. 2021 03 25; 384(12):1089-1100.
    View in: PubMed
    Score: 0,411
  2. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study. PLoS One. 2017; 12(12):e0188606.
    View in: PubMed
    Score: 0,328
  3. Reevaluating HIV vaccine clinical trials policy for infants. J Infect Dis. 2015 Feb 15; 211(4):501-3.
    View in: PubMed
    Score: 0,261
  4. Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect Dis. 2011 Jul; 11(7):507-15.
    View in: PubMed
    Score: 0,207
  5. HIV and pregnancy. BMJ. 2007 May 05; 334(7600):950-3.
    View in: PubMed
    Score: 0,157
  6. Immune-based prevention of mother-to-child HIV-1 transmission. Curr Opin Mol Ther. 2007 Apr; 9(2):168-75.
    View in: PubMed
    Score: 0,156
  7. Effect of HIV on women. AIDS Read. 2006 Jul; 16(7):365-8, 373-7.
    View in: PubMed
    Score: 0,148
  8. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS. 2005 Aug 12; 19(12):1289-97.
    View in: PubMed
    Score: 0,139
  9. Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. N Engl J Med. 2021 03 18; 384(11):1003-1014.
    View in: PubMed
    Score: 0,103
  10. Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial. PLoS One. 2021; 16(1):e0241708.
    View in: PubMed
    Score: 0,102
  11. Evaluation of the MUREX*ICE HIV-1.O.2 capture enzyme immunoassay for early identification of HIV-1 seroreverting infants in a developing country. Clin Diagn Virol. 1997 May; 8(1):1-8.
    View in: PubMed
    Score: 0,078
  12. Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap. Clin Vaccine Immunol. 2016 06; 23(6):496-506.
    View in: PubMed
    Score: 0,074
  13. Uptake of genital mucosal sampling in HVTN 097, a phase 1b HIV vaccine trial in South Africa. PLoS One. 2014; 9(11):e112303.
    View in: PubMed
    Score: 0,066
  14. KIR2DS4 allelic variants: Differential effects on in utero and intrapartum HIV-1 mother-to-child transmission. Clin Immunol. 2013 Dec; 149(3):498-508.
    View in: PubMed
    Score: 0,061
  15. Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. AIDS. 2011 Jan 02; 25(1):87-94.
    View in: PubMed
    Score: 0,051
  16. Natural killer cells that respond to human immunodeficiency virus type 1 (HIV-1) peptides are associated with control of HIV-1 infection. J Infect Dis. 2010 Nov 01; 202(9):1444-53.
    View in: PubMed
    Score: 0,050
  17. Development of a whole blood intracellular cytokine staining assay for mapping CD4(+) and CD8(+) T-cell responses across the HIV-1 genome. J Virol Methods. 2007 Sep; 144(1-2):115-21.
    View in: PubMed
    Score: 0,039
  18. Low maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses. Clin Vaccine Immunol. 2007 Apr; 14(4):348-54.
    View in: PubMed
    Score: 0,039
  19. In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr. 2006 Aug 15; 42(5):545-53.
    View in: PubMed
    Score: 0,037
  20. Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission. J Gen Virol. 2006 Jul; 87(Pt 7):2055-2065.
    View in: PubMed
    Score: 0,037
  21. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J Immunol. 2004 Oct 01; 173(7):4607-17.
    View in: PubMed
    Score: 0,033
  22. Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates. Virus Genes. 2003 Jan; 26(1):49-56.
    View in: PubMed
    Score: 0,029
  23. Correlation between CD4+ lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis. Pediatr Infect Dis J. 1999 Sep; 18(9):800-5.
    View in: PubMed
    Score: 0,023
  24. Maternal human leukocyte antigen-G (HLA-G) genetic variants associate with in utero mother-to-child transmission of HIV-1 in Black South Africans. Infect Genet Evol. 2015 Mar; 30:147-158.
    View in: PubMed
    Score: 0,017
  25. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. PLoS Med. 2009 Oct; 6(10):e1000172.
    View in: PubMed
    Score: 0,012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.